Lantheus Holdings (LNTH) Long-Term Investments (2024 - 2026)
Lantheus Holdings' (LNTH) quarterly Long-Term Investments came in at $58.3 million in Q1 2026, up 91.97% year-on-year from $30.4 million in Q1 2025, and up 5201.09% on a QoQ basis from $1.1 million in Q4 2025.
Lantheus Holdings (LNTH) Long-Term Investments (2024 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 3 years of Long-Term Investments data on file, last reported at $58.3 million in Q1 2026.
- On a quarterly basis, Long-Term Investments rose 91.97% year-over-year to $58.3 million in Q1 2026; TTM through Mar 2026 was $58.3 million, a 91.97% increase from a year earlier, with the FY2025 full-year figure at $1.1 million, changed N/A from the prior year.
- Long-Term Investments for Q1 2026 stood at $58.3 million, up from $1.1 million in the prior quarter.
- Over the last five years, Long-Term Investments for LNTH reached as high as $158.8 million in Q3 2024 and fell as low as $1.1 million in Q4 2025.
- Historically, Long-Term Investments has averaged $74.4 million across 3 years, with a median of $52.4 million in 2025.
- Across the five-year window, Long-Term Investments plunged 78.14% in 2025 and soared 91.97% in 2026, its largest moves.
- Year by year, Long-Term Investments stood at $158.8 million in 2024, then plunged by 99.31% to $1.1 million in 2025, then jumped by 5201.09% to $58.3 million in 2026.
- Per Business Quant data, the three most recent Long-Term Investments figures were $58.3 million in Q1 2026, $1.1 million in Q4 2025, and $46.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 58.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.31 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 46.47 Mn |
| Jun 30, 2025 | 45.07 Mn |
| Mar 31, 2025 | 30.38 Mn |
| Sep 30, 2024 | 158.79 Mn |
| Jun 30, 2024 | 116.42 Mn |
| Mar 31, 2024 | 138.96 Mn |